ReviewBiomedicines2024

Expanding the Perspective on PARP1 and Its Inhibitors in Cancer Therapy: From DNA Damage Repair to Immunomodulation.

Flurina Böhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.